Position in GILD
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,389
-$144 QoQ
Shares Held
11
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,243
of 2,265 holders
Holding Since
Mar 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PITTENGER & ANDERSON INC holds $56,834,770 across 10 Drug Manufacturers - General names. GILD ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
103,992 | $26,410,848 | |
| 2 | NVS |
Novartis AG
|
49,020 | $7,682,414 | |
| 3 | ABBV |
AbbVie Inc.
|
29,986 | $7,545,677 | |
| 4 | MRK |
Merck & Co., Inc.
|
50,965 | $6,549,002 | |
| 5 | AZN |
Astrazeneca PLC
|
32,459 | $6,154,875 | |
| 6 | LLY |
ELI LILLY & Co
|
1,077 | $1,291,786 | |
| 7 | AMGN |
Amgen Inc
|
3,003 | $1,087,446 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,849 | $106,539 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,389 | 11 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,533 | 11 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,350 | 11 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,221 | 11 | Shares | Sole | 2025-11-03 | |
| 2025-03-31 | $64,876 | 579 | Shares | Sole | 2025-05-01 | |
| 2023-12-31 | $36,454 | 450 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $33,723 | 450 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $34,681 | 450 | Shares | Sole | 2023-08-09 | |
| 2022-03-31 | $1,545 | 26 | Shares | Sole | 2022-04-28 | |
| No filing history on record for this holder in this stock. | ||||||